New Product

Apr 30, 2009

Premium

Waters this week introduced a new UPLC analytical solution for the characterization of 2-AB labeled glycans from glycoproteins.

The solution combines new Acquity UPLC BEH Glycan columns with the Acquity UPLC system equipped with fluorescence detection.

In a statement, Waters said the solution is being introduced at the request of scientists who want to apply UPLC technology to the development and analysis of glycans derived from therapeutic proteins. Regulations from the US Food and Drug Administration require that companies developing and manufacturing therapeutic proteins be able to accurately characterize the glycan attached to those proteins in order to ensure efficacy and safety of a biopharmaceutical product.

Filed under

Proteomics & Protein Research

FDA

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.